# Ganymede Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ganymede-bio

- Industry: Software
- Headquarters: Palo Alto, US
- Website: www.ganymede.bio
- Total disclosed funding: $15M
- Latest round: Series A (Jul 25, 2022)
- Investors on record: 1

## About

Founded in 2022 and based in California, US, Ganymede Bio, Inc. provides cloud infrastructure for the life sciences and manufacturing industries. Benson Lee and Nathan Clark are the co-founders of the company. In December 2022, Ganymede Bio, Inc. raised USD 12.75 million in series A funding from Caffeinated Capital.

The company offers a platform for whole-lab automation and data integration that enables users to write, test, and run integrations between anything in a lab. The firm provides a declarative library of high-level automation tools and bioinformatic functions, as well as the ability to virtualize integrations that can be developed using an internal scheme, inherit structure from apps, access open public databases, use ontologies, and more.

Ganymede generates a UI for mapping data that acts as tables for engineers' integrations. The platform also includes biologically aware types and connectors, the ability to store everything for auditing and debugging experiments, the ability to automate ingestion, self-service human-in-the-loop tooling, ML-powered data cleaning, and other features.

The organization plans to use the December 2022 funding to develop its cloud-native data platform, cloud IDE, and self-service tooling.

## Funding rounds

- Series A, Jul 25, 2022, $15M — Caffeinated Capital

## Investors

- Caffeinated Capital (https://capitalatlas.ai/funds/caffeinated-capital) — Series A